CG Oncology, Inc. Common stock
CGON · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Market Cap | $3,090,673 | $1,981,898 | $1,865,835 | $1,859,045 |
| - Cash | $45,145 | $14,624 | $41,472 | $257,068 |
| + Debt | $7,241 | $994 | $1,036 | $238 |
| Enterprise Value | $3,052,769 | $1,968,268 | $1,825,399 | $1,602,215 |
| Revenue | $1,666 | $0 | $52 | $456 |
| % Growth | – | -100% | -88.6% | – |
| Gross Profit | $89 | -$156 | $52 | $456 |
| % Margin | 5.3% | – | 100% | 100% |
| EBITDA | -$43,392 | -$41,270 | -$42,180 | -$38,049 |
| % Margin | -2,604.6% | – | -81,115.4% | -8,344.1% |
| Net Income | -$43,808 | -$41,426 | -$34,452 | -$31,798 |
| % Margin | -2,629.5% | – | -66,253.8% | -6,973.2% |
| EPS Diluted | -0.57 | -0.54 | -0.45 | -0.49 |
| % Growth | -5.6% | -20% | 8.2% | – |
| Operating Cash Flow | -$38,894 | -$27,959 | -$29,277 | -$20,662 |
| Capital Expenditures | -$97 | -$14 | -$16 | -$209 |
| Free Cash Flow | -$38,991 | -$27,973 | -$29,293 | -$20,871 |